A New Hope in Type 1 Diabetes Research | 2024 | TCOYD Virtual Diabetes Conference

Cutting-edge Type 1 Diabetes (T1D) research explained! Dr. Pettus reveals game-changing developments in 2024, which you should know! 🆕 Teplizumab (Tzield): FDA-approved drug delaying T1D onset 🧬 Stem cell therapies & gene editing for beta cell replacement 💉 Islet cell transplants without immunosuppression 🧪 Clinical trials for newly diagnosed Type 1 Diabetes patients ⏱️ In this video Dr. Perttus dive into: 1. T1D Explained: Autoimmune Process 2. New T1D Staging System 3. Teplizumab for T1D Prevention 4. Preserving Beta Cells in New Onset T1D 5. Beta Cell Replacement Strategies 6. Gene Therapy for Insulin Production 7. How to Join Clinical Trials 🔑 Takeaways: T1D risk screening C-peptide's role in type 1 diabetes management Vertex Pharmaceuticals' stem cell breakthroughs GKAA's innovative gene therapy approach 👨‍⚕️ Dr. Pettus shares insider insights on groundbreaking research and how YOU can get involved in shaping the future of T1D treatment! Access all online sessions here: https://tcoyd.org/vv-may-the-4th/ Learn diabetes with TCOYD: https://tcoyd.org Follow TCOYD's Instagram: / tcoyd TCOYD's Facebook: / tcoyd Listen to the podcast: https://tcoydthepodcast.transistor.fm The information contained in or provided through TCOYD content is for purposes of general consumer education only, and though it is professional medical advice, always consult your doctor for medical diagnosis and treatment. The use of this information is your full responsibility with the understanding and agreement that TCOYD is not liable for claim, loss, or damage occurring as a result of its use.